Skip to content
OpenCapital
Get started

Evolent Health, Inc. EVH Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Cencora logo
CencoraCOR
——

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%—

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s contingent consideration fair value adjustments?
Evolent Health, Inc. (EVH) reported contingent consideration fair value adjustments of $0 in Q1 2026.
How has Evolent Health, Inc.'s contingent consideration fair value adjustments changed year-over-year?
Evolent Health, Inc.'s contingent consideration fair value adjustments increased by 100.0% year-over-year, from -$280K to $0.
What is the long-term trend for Evolent Health, Inc.'s contingent consideration fair value adjustments?
Over 3 years (2021 to 2025), Evolent Health, Inc.'s contingent consideration fair value adjustments has grown at a -21.2% compound annual growth rate (CAGR), from $13.28M to $6.5M.